Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hepatology
Reference41 articles.
1. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
2. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015
3. Epidemiology and natural history of NAFLD and NASH;Ong;Clin Liver Dis,2007
4. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat Rev Gastroenterol Hepatol,2013
5. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Alimen Pharmacol Ther,2011
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints;American Journal of Gastroenterology;2024-07-17
2. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis;Seminars in Liver Disease;2024-07-09
3. Soluble CD46 as a diagnostic marker of hepatic steatosis;eBioMedicine;2024-06
4. Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions;CHILD`S HEALTH;2024-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3